Dawson Laura A, Ten Haken Randall K
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Semin Radiat Oncol. 2005 Oct;15(4):279-83. doi: 10.1016/j.semradonc.2005.04.005.
The use of conformal radiotherapy (RT) and the follow-up of patients for radiation liver toxicities has led to a quantitative understanding of partial liver RT tolerance. The most common toxicity is radiation-induced liver disease (RILD), a syndrome of anicteric ascites and hepatomegaly. Elevation of transaminases and reactivation of viral hepatitis have also been reported after liver RT. The Lyman normal tissue complication probability (NTCP) model and a local damage-organ injury NTCP model have been used to describe the partial tolerance of the liver to RT. The liver exhibits a large volume effect and a low threshold volume for RILD. The RT tolerance of the liver is reduced in patients with primary liver cancer versus metastases. Elevated transaminases are more common in the presence of poor liver function and hepatitis B infection. If the effective liver volume irradiated is less than 25%, very high RT doses may be delivered with little risk of liver toxicity. The mean liver doses associated with a 5% risk of classic RILD for primary and metastatic liver cancer are 28 Gy and 32 Gy, respectively, in 2 Gy per fraction.
适形放疗(RT)的应用以及对患者放射性肝毒性的随访,使得人们对部分肝脏放疗耐受性有了定量的认识。最常见的毒性反应是放射性肝病(RILD),这是一种无黄疸性腹水和肝肿大的综合征。肝脏放疗后也有转氨酶升高和病毒性肝炎再激活的报道。Lyman正常组织并发症概率(NTCP)模型和局部损伤-器官损伤NTCP模型已被用于描述肝脏对放疗的部分耐受性。肝脏表现出较大的体积效应,且发生RILD的阈值体积较低。与转移性肝癌患者相比,原发性肝癌患者肝脏的放疗耐受性降低。肝功能差和感染乙型肝炎时,转氨酶升高更为常见。如果照射的有效肝脏体积小于25%,则可以给予非常高的放疗剂量,而肝脏毒性风险很小。对于原发性和转移性肝癌,每次分割剂量为2 Gy时,发生典型RILD风险为5%的平均肝脏剂量分别为28 Gy和32 Gy。